# Safety Study of CTX-100 Inhalation Solution (Formerly ETX-100)

> **NCT00993707** · PHASE2 · COMPLETED · sponsor: **Turino, Gerard, M.D.** · enrollment: 11 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DRUG:** CTX-100 (formerly ETX-100) (hyaluronic acid)

## Key facts

- **NCT ID:** NCT00993707
- **Lead sponsor:** Turino, Gerard, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2019-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00993707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00993707, "Safety Study of CTX-100 Inhalation Solution (Formerly ETX-100)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00993707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*